TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
NorthX Biologics AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 150,341 | 135,116 | 93,827 |
Financial expenses | 746 | 421 | 619 |
Earnings before taxes | -11,108 | -31,048 | -43,246 |
EBITDA | -4,101 | -21,884 | -36,576 |
Total assets | 261,461 | 215,961 | 191,535 |
Current assets | 130,569 | 101,857 | 83,972 |
Current liabilities | 253,988 | 213,871 | 183,069 |
Equity capital | 7,473 | 2,090 | 8,466 |
- share capital | 95 | 98 | 105 |
Employees (average) | 129 | 124 | 104 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 2.9% | 1.0% | 4.4% |
Turnover per employee | 1,165 | 1,090 | 902 |
Profit as a percentage of turnover | -7.4% | -23.0% | -46.1% |
Return on assets (ROA) | -4.0% | -14.2% | -22.3% |
Current ratio | 51.4% | 47.6% | 45.9% |
Return on equity (ROE) | -148.6% | -1485.6% | -510.8% |
Change turnover | 19,286 | 47,771 | 15,707 |
Change turnover % | 15% | 55% | 20% |
Chg. No. of employees | 5 | 20 | 24 |
Chg. No. of employees % | 4% | 19% | 30% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.